Completed

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

J1I-MC-GZBB - ClinicalTrials.gov - NCT04143802

The main purpose of this study is to learn about the side effects of LY3437943 when given to participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943, dulaglutide, or placebo given just under the skin.
How long will I be in the trial?
The study will last up to about 5 months and will include 16 visits to the study center.
Email
Completed

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)

J1I-MC-GZBB - ClinicalTrials.gov - NCT04143802

The main purpose of this study is to learn about the side effects of LY3437943 when given to participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943, dulaglutide, or placebo given just under the skin.
How long will I be in the trial?
The study will last up to about 5 months and will include 16 visits to the study center.
Email

Key Requirements

Age :

20-70

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

20-70

Sex

All

Participants must

Participants must be diagnosed with type 2 diabetes for at least six months

Participants must have stable body weight for the last 3 months

Participants must be overweight or very overweight - Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant

Participants must NOT

Participants must not have known complication of diabetes

Participants must not have Type 1 diabetes mellitus

Participants must not have uncontrolled diabetes, (meaning that they required hospitalization for treatment of life-threatening complications of diabetes in the last six months)

Participants must not have had severe low blood sugar requiring emergency treatment

Participants must not have inflammation of the pancreas

Participants must not have known liver disease

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY3437943, Dulaglutide, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

75

Trial Dates

December 2019 - December 2020

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

20-70

Sex

All

Participants must

Participants must be diagnosed with type 2 diabetes for at least six months

Participants must have stable body weight for the last 3 months

Participants must be overweight or very overweight - Male participants must agree to use birth control during the study and for 90 days afterward and female participants must not be able to get pregnant

Participants must NOT

Participants must not have known complication of diabetes

Participants must not have Type 1 diabetes mellitus

Participants must not have uncontrolled diabetes, (meaning that they required hospitalization for treatment of life-threatening complications of diabetes in the last six months)

Participants must not have had severe low blood sugar requiring emergency treatment

Participants must not have inflammation of the pancreas

Participants must not have known liver disease

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

LY3437943, Dulaglutide, Placebo

Could I receive a Placebo?

yes

Enrollment Goal

75

Trial Dates

December 2019 - December 2020

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Adult Type 2 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?